LFVNConsumer Defensive · Packaged FoodsThe 2 Wall Street analysts covering LifeVantage Corp. hold a median 12-month price target of $7 — +5.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 78 of 100 as at 22 Aug 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores LifeVantage Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (99): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Momentum (15): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on LFVN, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +5.1% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 7 May 2026 | Lake Street | Downgrade | Hold | $5.00 |
| 7 May 2026 | Lake Street | Downgrade | Hold | — |
| 18 Feb 2026 | Freedom Broker | Maintains | Buy | — |
| 14 Nov 2025 | Freedom Broker | Maintains | Buy | — |
| 14 Jan 2025 | Craig-Hallum | Initiates | Buy | — |
| 19 Dec 2024 | Lake Street | Initiates | Buy | — |
| 12 Feb 2014 | Imperial Capital | Initiates | In-Line | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. LFVN appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 48% of US stocks
Cheaper than 85% of US stocks
Cheaper than 40% of US stocks
Cheaper than 45% of US stocks
Higher than 10% of US stocks
Higher than 8% of US stocks
Higher than 90% of US stocks
Higher than 53% of US stocks
Higher than 55% of US stocks
Higher than 78% of US stocks
Higher than 83% of US stocks
Higher than 65% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own LifeVantage Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
LifeVantage Corporation announced that its Board of Directors approved a quarterly cash dividend of $0.050 per share of common stock. The dividend will be paid on September 15, 2026 to stockholders of record at the close of business on September 1, 2026.
Why it matters — A declared cash dividend is relevant to LifeVantage watchers as it signals the company's ongoing distribution of returns to its shareholders.
LifeVantage Corporation announced it will release financial results for its fourth quarter and full fiscal year ended June 30, 2026, after the stock market closes on Thursday, August 27, 2026, and will hold a conference call for investors at 2:30 p.m. Mountain Time that same day.
Why it matters — The announcement provides LFVN watchers with the scheduled date and time for the company's fiscal year-end earnings release and investor conference call.
LifeVantage announced that its Board of Directors granted inducement awards to Terrence Moorehead, the company's new President and Chief Executive Officer, under the 2026 New Employee Long-Term Incentive Plan. The awards were granted as an inducement material to Moorehead's employment in accordance with Nasdaq Listing Rule 5635(c)(4).
Why it matters — A LifeVantage watcher would care because it confirms the onboarding of a new CEO under a long-term incentive plan, signalling a formal executive leadership transition at the company.
LifeVantage announced that Terrence Moorehead has officially joined the company as President and Chief Executive Officer and as a member of the Board of Directors. His appointment, which was previously announced on April 16, 2026, has now taken effect.
Why it matters — A LFVN watcher would care because the health and wellness company has now formally installed its new CEO, completing a leadership transition announced months earlier.
The 2 Wall Street analysts covering LifeVantage Corp. have a median 12-month price target of $7, with estimates ranging from $5 to $9. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 2 analysts covering LifeVantage Corp., 1 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks LifeVantage Corp. 78 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 22 Aug 2026, LifeVantage Corp. ranks 78 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (99 of 100).
No one can know that. What the data says: the median 12-month target from 2 analysts implies +5.1% from the last close, and Ticker Nerd's factor model ranks LifeVantage Corp. 78 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering LifeVantage Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for LFVN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $5 to $9 over the next 12 months.
LifeVantage Corp. returned -45.5% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
LifeVantage Corporation is a health and wellness company headquartered in Lehi, Utah, focused on nutrigenomics and clinically researched nutritional products. The company identifies, develops, and markets nutraceutical dietary supplements designed to support cellular health, oxidative stress management, and overall well-being.
The most recent item we track (GlobeNewsWire, 21 Aug 2026): "LifeVantage Declares Quarterly Dividend". LifeVantage Corporation announced that its Board of Directors approved a quarterly cash dividend of $0.050 per share of common stock. The dividend will be paid on September 15, 2026 to stockholders of record at the close of business on September 1, 2026.
LifeVantage Corporation is a health and wellness company headquartered in Lehi, Utah, focused on nutrigenomics and clinically researched nutritional products. The company identifies, develops, and markets nutraceutical dietary supplements designed to support cellular health, oxidative stress management, and overall well-being. Its portfolio includes branded products such as Protandim nutrigenomic activators, nootropic formulations, pre- and probiotics, energy drink mixes, weight management solutions, and skin and hair care lines. LifeVantage distributes its products primarily through a direct selling model, engaging independent distributors and customers across markets including the United States, Asia-Pacific, Europe, and Latin America. The company positions itself at the intersection of nutrition and gene expression, targeting consumers interested in proactive wellness, healthy aging, and performance support. By combining scientific research, proprietary formulations, and a network-based distribution approach, LifeVantage plays a specialized role in the global consumer health and personal care market.
CEO Mr. Terrence O. Moorehead · 232 employees · United States · https://www.lifevantage.com